HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Optical coherence tomography to monitor photodynamic therapy in pathological myopia.

AbstractAIM:
To evaluate the role of optical coherence tomography (OCT) in determining choroidal neovascularisation (CNV) activity before and after photodynamic therapy (PDT) in patients with pathological myopia.
METHODS:
33 patients (33 eyes) with pathological myopia and being treated with PDT were included. Every 3 months all patients were evaluated and presence or absence of leakage on fluorescein angiography, presence of intraretinal or subretinal fluid on OCT, and macular and choroidal neovascular complex thickness on OCT, were determined at each examination.
RESULTS:
The macular thickness decreased significantly after PDT at 6 months (p = 0.001) and at 12 months follow up (p = 0.01). However, no significant changes in CNV thickness were measured after PDT at 6 months of follow up (p = 0.418) and at 12 months of follow up (p = 0.521). Once the diagnosis of CNV associated with pathological myopia was established, before treatment, OCT had a sensitivity of 96.96% for detecting CNV activity. After treatment, OCT had a good sensitivity (95.23%) and a moderate specificity (69,69%) in determining CNV activity, which resulted in a diagnostic efficiency (proportion of correct results) of 79.62%.
CONCLUSIONS:
OCT appears to be useful for indicating CNV activity. Therefore, it may serve as a complementary technique for deciding the need for PDT and re-treatment in patients with pathological myopia.
AuthorsA García-Layana, A Salinas-Alamán, M J Maldonado, C Sainz-Gómez, A Fernández-Hortelano
JournalThe British journal of ophthalmology (Br J Ophthalmol) Vol. 90 Issue 5 Pg. 555-8 (May 2006) ISSN: 0007-1161 [Print] England
PMID16464970 (Publication Type: Evaluation Study, Journal Article)
Topics
  • Adult
  • Choroid (pathology)
  • Choroidal Neovascularization (drug therapy, pathology)
  • Extracellular Fluid
  • Female
  • Fluorescein Angiography
  • Humans
  • Male
  • Middle Aged
  • Myopia, Degenerative (drug therapy, pathology)
  • Photochemotherapy
  • Prospective Studies
  • Retina (pathology)
  • Sensitivity and Specificity
  • Tomography, Optical Coherence
  • Visual Acuity

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: